한국어
English
日本語
中文(简体)
Myfortic Extended-Release Tablets 360 mg (Mycophenolate Sodium)
384.8mg
Tablet · Prescription medication
Novartis Korea Ltd.
Mycophenolate sodium is an immunosuppressant that prevents rejection after organ transplantation.
MFDS ingredient code M099656
Mycophenolate sodium belongs to the class of immunosuppressants and is primarily used to suppress the immune response in organ transplant patients to prevent rejection of the transplanted organ. This ingredient inhibits the proliferation of immune cells through non-specific immunosuppressive action.
Mycophenolate sodium reduces the immune response by interfering with the synthesis of nucleic acids required for the proliferation of immune cells. This action suppresses the activity of immune cells that attack the transplanted organ, preventing rejection.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other immunosuppressants, mycophenolate sodium selectively inhibits specific enzymes to block immune cell proliferation. As a result, it has a relatively different side effect profile and is widely used in organ transplant patients.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
